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Chronic heart failure is a major public-health problem with a high prevalence, high 
mortality and complex treatment. A comprehensive analysis is needed to provide 
optimal therapy to these patients. Non-invasive imaging plays a central part by 
offering a complete approach in patients with ischemic heart disease (IHD). Car-
diac magnetic resonance imaging (CMR) has emerged as an established advanced 
multi-parametric imaging modality for the functional and anatomical assessment of 
cardiovascular disease. This review describes the practical aspects of CMR imaging, 
and then discusses the role of CMR in the diagnosis and management of chronic 
IHD, its infarct related complications, such as secondary mitral regurgitation, left 
ventricular (LV) thrombus, and ventricular tachycardia (VT).
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Introduction
Chronic heart failure has become one of the clinically most important diseases of the heart. The prevalence is high, the treatment is complex, and the mortality 
is significant. The most detailed report comes from 
the update of heart disease and stroke statistics from 
the American Heart Association.1 A careful and 
comprehensive analysis is needed to provide optimal 
(and personalized) therapy to heart failure patients. 
Most of the information can be provided by non-
invasive imaging. 
Cardiovascular magnetic resonance (CMR) is an 
established advanced cross-sectional imaging modality 
for the functional and anatomical assessment of a 
wide range of cardiovascular disease. CMR is safe, 
does not use ionising radiation, provides diagnostic 
and prognostic information, and guides patient 
management. One of the key advantages of CMR is 
its multi-parametric approach, due to the availability 
of numerous different pulse sequences which can 
be applied to interrogate different aspects of the 
cardiovascular system and diagnose its pathological 
processes.2 CMR offers a unique multi-parametric 
assessment, detailing anatomy, function and flow, 
delineating scar from healthy myocardium, providing 
accurate tissue characterisation and with the addition 
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of stress techniques, can identify inducible myocardial 
ischaemia. A CMR study typically includes cine 
imaging in multiple planes for assessment of left 
ventricular (LV) volumes and global and regional 
function, stress and rest perfusion for myocardial 
ischemia and late gadolinium enhancement (LGE) 
for delineation of scar and assessment of viability. 
The combination of the above techniques in a single 
multi-parametric exam allows the quantification of 
LV ejection fraction, ischemic burden and determines 
myocardial viability, which can be used to risk-stratify 
patients and guide revascularisation.3 See table 1.
Global and regional LV volumetric 
assessment 
Cine cardiac magnetic resonance imaging of parallel, 
contiguous short-axis slices covering the entire 
heart over a user-defined number of cardiac phases 
has become a reference standard by which to assess 
ventricular function and structure. Global left ventricle 
and right ventricle volumes and mass are derived 
from cine CMR without the need for any geometrical 
assumptions, applying to ventricles of all sizes and 
shapes, even to those that have experienced extensive 
remodeling.5 Cine CMR with steady-state free 
precession (SSFP)—a relatively recent innovation with 
high signal-to-noise and tissue-to-blood contrast—
enables an accurate identification of even subtle 
regional wall motion abnormalities.6 In patients with 
heart failure, cine CMR demonstrates superiority over 
other non-invasive techniques, showing less inter-study 
variability and better reproducibility of the volumetric 
results. The most common measures quantifiable by 
cardiac cine CMR are the ventricular dimensions and 
volumes, myocardial mass, and derived quantities such 
as ejection fraction, stroke volume, and cardiac output. 
Additional measures relate to the shape of the ventricle, 
such as the ratio of the long axis to the short axis, which 
plays an important part in the pathogenesis of mitral 
regurgitation. A related measure of left ventricular 
shape is the sphericity index, defined as the ratio of 
the major axis to the minor axis of the left ventricle.7 
See Figure 1.4
Myocardial stress perfusion studies 
Basic pathophysiologic principles of coronary 
blood flow and myocardial perfusion apply also 
in cardiac magnetic resonance imaging perfusion 
interpretation. Briefly, in resting conditions, due to 
the coronary vasodilator reserve, myocardial perfusion 
is not altered until the coronary artery is 85-90% 
narrowed. In contrast, during stress the myocardium 
distal to less severe coronary stenosis (i.e. between 
50 to 85%) may become ischemic and the coronary 
table 1. Standard cardiovascular magnetic resonance (CMR) protocol used for assessing ischaemic heart disease (IHD) 
with their specific clinical utility4  
IHD assessment CMR protocol sequences Clinical utility
Static dark blood images of the thorax (HASTE sequence) Demonstrate anatomy and extra cardiac abnormalities
Bright blood cine images in the following planes
2 Chamber (vertical long axis)
4 Chamber (horizontal long axis)
3 Chamber
Short axis (from base to apex of heart)
Left ventricular outflow tract (LVOT)
Right ventricular outflow tract (RVOT)




Adenosine stress/rest perfusion or
Dobutamine stress wall motion analysis
Myocardial perfusion analysis
Myocardial contractile reserve
Post-gadolinium enhancement static images
 Early Detect ventricular thrombus and microvascular obstruction
 Late Demonstrate myocardial fibrosis
Flow studies in breath hold and free breathing Valvular functional analysis
Coronary artery imaging Assess origins and proximal course
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artery stenosis can be considered hemodynamically 
significant. Demonstration of myocardial ischaemia 
can be performed with either vasodilatory stress 
agents (adenosine, regadenoson and less commonly 
dipyridamole or nicorandil) or with an inotropic 
stress agent (dobutamine). Vasodilatory stress is the 
preferred method with a bolus of Gadolinium (Gd)-
based contrast agents (GBCA) delivered at peak stress. 
On first pass perfusion CMR, relative hypoperfusion 
indicating ischaemia is detected by reduced/delayed 
peak signal intensity during the myocardial contrast 
passage. Inotropic stress is mostly used to detect wall 
motion abnormalities in the presence of functionally 
significant coronary stenosis without the need for a 
GBCA although first pass perfusion imaging at peak 
inotropic stress may also be performed for additional 
value.8 Low-dose dobutamine stress CMR (5-10 mcg/
kg/min) relies on the demonstration of inotropic 
reserve in post-ischaemic viable myocardium. Cine 
imaging is performed at each stage of inotropic stress to 
assess all segments of the left ventricular myocardium 
in order to determine wall thickness and contractility. 
A 2mm, or more, increase in systolic wall thickness 
during inotropic stress infers myocardial viability.9 At 
present this technique has been well validated, showing 
similar or better accuracies when compared to routinely 
used techniques such SPECT imaging10 In a meta-
analysis by Nandalur et al. including 24 studies (1516 
patients, high disease prevalence), perfusion imaging 
demonstrated a sensitivity of 91% and a specificity 
of 81%.11 Compared to stress echocardiography, 
MRI provides reliable image quality not limited 
by the adequacy of the acoustic window. Per stress 
level, images can be easily acquired in standardized 
(repeatable) planes, and easily compared on an off-line 
workstation reducing operator-dependency. Patients 
with poor acoustic windows benefit the most from 
CMR stress testing. See Figure 2.4
Late gadolinium enhancement for scar 
detection and viability assessment  
Gadolinium contrast used with CMR remains 
confined to the extracellular space in normal myocar-
dium. Within infarcted myocardium, the volume of 
distribution for gadolinium contrast is significantly 
expanded, reaching 60–70% in scar tissue. As early 
as 3-4 min after administration of gadolinium con-
trast, the expanded distribution volume can be reli-
ably detected with CMR to demarcate non viable 
myocardium,12 with at least 4–6-fold greater spatial 
Figure 1. Standard planes of image acquisition on cardiovascular magnetic resonance (CMR) imaging. 
(A) Two chamber (B) Three chamber (C) Four chamber (D) Left ventricular outflow tract (LVOT) (E) 
Right ventricular outflow tract (RVOT) (F) Sino-atrial (SA) base (G) SA mid ventricle (F) SA apical 
ventricle. AA, ascending aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right 
atrium; RV, right ventricle.4
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resolution and a greater contrast-to-noise ratio than 
can be achieved with nuclear scintigraphy. The focal 
signal hyperintensity of infarcted myocardium, or 
myocardial scar tissue, is highlighted by suppress-
ing the signal from normal myocardium.13 Late 
gadolinium enhancement (LGE) images delineate 
the transmural extent of infarction (Figure 3),14 
thereby distinguishing between reversible and ir-
reversible myocardial injury, regardless of the extent 
of wall motion at rest, the age of the infarct, or the 
reperfusion status.15
Late Gadolinium Enhancement (LGE) imaging is 
consistently more sensitive and specific than any other 
techniques in detecting and sizing the spatial extent of 
myocardial infarction.15 The transmural extent of LGE 
can predict the response of left ventricular function to 
b-blocker therapy in patients with heart failure.16 Orn 
et al.17 found that scar size assessed by CMR was the 
strongest independent predictor of ejection fraction and 
left ventricular volumes in acute myocardial infarction, 
and of patients with heart failure. The transmural extent 
of hyper-enhancement predicts functional improve-
ment after revascularisation.18 Segments with <25% 
of transmural hyper-enhancement are likely to exhibit 
functional recovery, whilst those segments with >75% 
transmurality are unlikely to benefit from revascularisa-
tion, irrespective of the extent of the resting wall motion 
abnormality.19 Furthermore transmurality of LGE is 
a stronger predictor of regional and global functional 
recovery following revascularization than resting end 
diastolic wall thickness.20 The assessment of myocardial 
viability using a 50% transmural cut off on LGE imag-
ing has been reported to have a sensitivity of 95% (95% 
CI: 93-97%) and specificity of 51% (40-62%) to predict 
segmental functional recovery following revascularisa-
tion. Inotropic reserve assessed by low dose dobutamine 
has significantly higher specificity (91%) suggesting a 
combination of the two techniques might improve di-
agnostic performance for those segments with 25-75% 
of transmural LGE.21 It was shown recently that CMR 
measurements of gadolinium distribution volumes in vi-
able myocardium provide a novel marker of extracellular 
remodeling and diffuse fibrosis in patients with heart 
failure and dilated cardiomyopathy,22 pointing to the 
versatility of CMR for extensive tissue characterization 
in patients with heart failure.
Infarct-related complications
CMR can also assess complications after myocardial 
infarction, such as left ventricular mural thrombus, 
aneurysmal dilatation, and papillary muscle involve-
ment causing mitral regurgitation and rupture of the 
interventricular septum.23 Ventricular thrombi are 
easily missed on transthoracic echocardiography es-
pecially when located in the LV apex or when trapped 
within the endocardial trabeculations. Thrombus is 
an avascular structure, on LGE images it usually ap-
pears as a mass with low signal intensity surrounded 
by areas of high signal intensity such as cavity blood 
(Figure 4).24
Secondary mitral regurgitation occurs frequently 
in patients with ischemic heart failure, and is charac-
terized by a combination of reduced LV closing forces 
(due to LV dysfunction or dyssynchrony) and global 
and regional LV remodeling which leads to distortion 
of the subvalvular apparatus of the mitral valve, dis-
placement of the papillary muscles, tethering of the 
mitral leaflets, and failure of mitral valve coaptation. 
Secondary mitral regurgitation results in LV volume 
overload, which further worsens LV remodeling and 
mitral valve incompetence. The presence of significant 
secondary mitral regurgitation provides incremen-
Figure 2. Short Axis LV mid (A, C) and apical cavity (B, D) 
views in peak stress (A, B) and rest (C, D). Note significant 
subendocardial stress induced perfusion defect (arrow) in 
the antero septal wall which completely resolves at rest. LV, 
left ventricle; RV, right ventricle.4
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tal prognostic information over LVEF. Significant 
secondary mitral regurgitation was associated with 
increased risk of heart failure hospitalization and all 
cause mortality.25 Therefore, accurate quantification 
of secondary mitral regurgitation severity is crucial for 
clinical decision making in heart failure patients. Two 
Figure 3. This figure shows two different patients, with the top row showing a lateral 
infarction, and the bottom row showing an anterior infarction. The left column (A and 
C) shows single frames from gradient echo cines, and the right column (B and D) shows 
the gadolinium enhanced images. The bright areas in B and D are infarcted tissue which 
is brightly enhanced (straight arrows). The infarct in the short axis plane (B) extends from 
the inferior wall to the anterolateral wall, and is mainly non-transmural. In particular, 
at 4 o’clock a significant rim of viable epicardial tissue is present and wall thickness is 
preserved. However, wall thinning has occurred elsewhere where the transmural extent 
of infarction is greater. The infarct in the anterior wall of the vertical long axis plane (D) 
is transmural, however, and considerably greater thinning and ventricular remodeling 
has taken place. This technique allows transmural high resolution infarct depiction 
in-vivo for the first time. The curved arrow shows a pericardial effusion. Reproduced 
from Rajappan et al., Eur J Heart Failure. 2000;2:241–52.14
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dimensional echocardiography remains the mainstay 
imaging technique to assess the severity and mecha-
nism of secondary mitral regurgitation.26
 The suitability for surgical restrictive mitral valve 
annulopasty is influenced by several geometrical aspects 
of the mitral valve and left ventricle, and also by the 
presence of extensive myocardial scar, which has been 
associated with increased mortality rates after surgical 
repair.27
Furthermore CMR is able to detect, accurately 
size and assess the haemodynamic significance 
of a post-infarct ventricular septal defect (VSD), 
potentially guiding the suitability and sizing for 
a percutaneous VSD closure device.28 Accurate 
volumetric quantification of both the right and left 
ventricles, or comparison of flow measurements of 
the pulmonary and systemic circulations, can also 
be used to calculate the shunt ratio. CMR is also 
useful in the detection of ventricular aneurysm, 
pseudoaneurysms and assessment and quantification 
of mitral regurgitation post AMI. Furthermore, the 
high spatial resolution of CMR allows the detection 
and quantitation of RV infarction with LGE and 
cine imaging, which has additional prognostic 
importance.29
Patients with ischemic heart failure and depressed 
LVEF (<35%) have an increased risk of arrhythmic 
death.30 Left ventricular volumes and LVEF are im-
portant parameters for the risk stratification and man-
agement (particularly device therapy) of heart failure 
patients. CMR techniques can capture and characterize 
the multifaceted process of infarct remodeling, and 
shed light on novel markers beyond infarct and scar 
size, cavity enlargement, and left ventricular function. 
The border zone of infarction with intermediate signal 
intensity on LGE images provides a stronger associa-
tion with electrophysiological substrates of ventricular 
arrhythmias than with left ventricular ejection fraction. 
The border zone was strongly associated with post 
myocardial infarction mortality in a small group of 
patients post myocardial infarction.31 See Figure 5.32
Various trials have demonstrated the prophylactic 
benefit of an ICD in these patients. However, the 
percentage of patients that require ICD therapy (ap-
propriate shocks) to prevent ventricular tachycardia/
fibrillation (VT/VF) at follow-up is relatively low, sug-
gesting that a substantial percentage of patients may 
not benefit from ICD.33 Currently, the LVEF (±30-
35%) used as the main selection criterium for ICD 
therapy.34 The precise substrate for VT/VF however 
is unknown, but may be related to scar tissue (infarct 
zone) and the heterogenous border zone around the in-
farct core (mixture of viable myocardium interspersed 
with fibrous and scar tissue). Non-invasive imaging 
may eventually help in patient selection for ICD im-
plantation. The presence, extent, and characteristics 
of myocardial scar assessed with contrast-enhanced 
MRI have incremental prognostic value over LVEF to 
Figure 4. Left ventricular (LV) thrombus formation on delayed gadolinium contrast cardiac MRI and 
transthoracic echocardiography. Transthoracic echocardiographic appearance of a thrombus (asterisk) 
in the apex of the left ventricle (A); cine cardiovascular magnetic resonance of the same patient also 
delineates the apical thrombus (B); late gadolinium enhancement imaging clearly confirms the avascular 
non-enhancing thrombus (asterisk, dark) close to the transmural infarcted myocardium (bright 
hyperenhanced, black arrowheads) with areas of microvascular obstruction (black, white arrowheads) 
(C). Courtesy of Dr A C van Rossum, Dr R Nijveldt, Department of Cardiology, VU University Medical 
Center, Amsterdam, the Netherlands, and Dr B J Bouma, Department of Cardiology, Academic Medical 
Center, Amsterdam, the Netherlands.
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predict the occurrence of VT/VF.35 Subsequent stud-
ies quantifying the extent of contrast-enhanced tissue 
(scar mass) revealed that the arrhythmic risk increased 
significantly when the scar mass exceeded 1.4-5% of 
the LV volume.36
Conclusion
Patients with chronic heart failure need a careful 
and stepwise diagnostic analysis. Cardiac magnetic 
resonance imaging allows comprehensive and accurate 
assessment of patients chronic ischemic heart failure 
and it is the current gold standard imaging modality 
for assessment of ventricular function. The complete 
information provided from CMR, both anatomical 
and functional assessment, can guides physician to 
understand more about the pathophysiological process 
of ischemic heart disease, and a better management in 
the intervention of chronic heart failure and its related 
complications.   
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